Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
about
Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasisTargeting the Wolbachia cell division protein FtsZ as a new approach for antifilarial therapyNew insights into the evolution of Wolbachia infections in filarial nematodes inferred from a large range of screened speciesWolbachia: Can we save lives with a great pandemic?Anti-filarial activity of antibiotic therapy is due to extensive apoptosis after Wolbachia depletion from filarial nematodes.Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.Wolbachia lipoproteins: abundance, localisation and serology of Wolbachia peptidoglycan associated lipoprotein and the Type IV Secretion System component, VirB6 from Brugia malayi and Aedes albopictus.Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis.Human filarial Wolbachia lipopeptide directly activates human neutrophils in vitroExtensively duplicated and transcriptionally active recent lateral gene transfer from a bacterial Wolbachia endosymbiont to its host filarial nematode Brugia malayi.Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis.Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel diseaseModulation of phosphofructokinase (PFK) from Setaria cervi, a bovine filarial parasite, by different effectors and its interaction with some antifilarials.Homology modeling of NAD+-dependent DNA ligase of the Wolbachia endosymbiont of Brugia malayi and its drug target potential using dispiro-cycloalkanones.Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host.Autophagy regulates Wolbachia populations across diverse symbiotic associations.Identification and profiling of circulating antigens by screening with the sera from schistosomiasis japonica patients.Filarial and Wolbachia genomicsA phylum level analysis reveals lipoprotein biosynthesis to be a fundamental property of bacteria.Lipoproteins in bacteria: structures and biosynthetic pathways.Wolbachia filarial interactions.Current drug targets for helminthic diseases.Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.Toll-like receptor signaling in parasitic infections.Identification and prioritization of novel anti-Wolbachia chemotypes from screening a 10,000-compound diversity library.Antifilarial activity of caffeic acid phenethyl ester on Brugia pahangi in vitro and in vivo.Equations of bark thickness and volume profiles at different heights with easy-measurement variablesDrugs and Targets to Perturb the Symbiosis of Wolbachia and Filarial Nematodes
P2860
Q28294770-20328927-7A13-4E44-946F-C5B21264CAD3Q28478176-DCB3A65D-6849-4424-BAD6-624271F79216Q28743347-0929DB86-1A87-497D-BEC6-6C2F7C61214FQ30352017-41A0DD26-8E88-41CE-83F4-13B0191AF840Q34071384-DB94C9B2-4B34-4BF6-97E4-F04360E5834EQ34198127-861B93CF-427D-4666-AAD7-8E1F40AA7519Q34339870-5944BEBD-4DFF-4E4F-B682-6C79962F8D1EQ34454263-F78D66C4-23C4-4115-BE68-AC5E4CC89614Q34805265-801C4520-C129-47A3-967A-2FF369FE96E3Q34993097-AA67082D-0F14-438C-B19B-377FD58921F8Q35297570-FF71A062-DE4E-4236-8510-0FD87DFEDB6AQ35420431-1C78496D-C007-4D40-9BAD-28EA08E84AF2Q35680364-E105C26F-0C47-4BFA-B0C2-5A811BE09046Q35746127-5FCF2FDE-E480-4AF3-A693-7E968B330046Q35848894-50D83962-63CC-48FF-8C08-7A9088E7569AQ36056638-B59C78AF-AE12-48C6-8B72-6997EDFE87FEQ36165870-432F6087-4716-4BCE-A0B9-FD6A8028BEE7Q36266443-A4A64943-2B61-44F3-BD6D-C7D72190AF74Q37992840-80609A8D-1816-475E-9E03-A3437284CEAEQ38055247-D7DCEB59-0BF2-43E4-BE50-F1F43B574F9DQ38064892-5886101D-8980-4089-8B37-41533EAE4F05Q38093067-57CB9AD0-DBD1-4859-AC69-87A134466C9AQ38163392-4E00EC9E-2EB3-4DEC-AF4C-0A6EFD412DC4Q38432017-467457F8-9447-43BE-9AEC-D40BD4C75A4FQ41678406-9666C759-1931-4E0A-8231-1D43A2A89CD8Q44169309-128CB974-D49C-475A-864A-901E2ED8DE22Q57023521-5B441438-504E-4F10-B4DD-5D2D40F29820Q57179758-E949E38C-C79B-48FA-899E-7D87DB1FD1C5
P2860
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
@ast
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
@en
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
@nl
type
label
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
@ast
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
@en
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
@nl
prefLabel
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
@ast
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
@en
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
@nl
P2093
P2860
P356
P1433
P1476
Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
@en
P2093
Ana Guimarães
Barton E Slatko
Kelly L Johnston
P2860
P2888
P356
10.1186/1756-3305-3-99
P577
2010-10-14T00:00:00Z
P5875
P6179
1014438947